We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

116 hedge funds and large institutions have $940M invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more call options, than puts

Call options by funds: $6.85M | Put options by funds: $2.71M

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

58% more capital invested

Capital invested by funds: $596M → $940M (+$344M)

53% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 17

18% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 33

8% more funds holding

Funds holding: 107 → 116 (+9)

Holders
116
Holders Change
+9
Holders Change %
+8.41%
% of All Funds
3.37%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.15%
New
26
Increased
39
Reduced
33
Closed
17
Calls
$6.85M
Puts
$2.71M
Net Calls
+$4.14M
Net Calls Change
+$3.17M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$31.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.5M
3
BBA
Baker Bros. Advisors
New York
+$19.4M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$16.4M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$29.4M
2
BC
Broadfin Capital
New York
-$13.5M
3
QF
QVT Financial
New York
-$10.3M
4
PA
Perceptive Advisors
New York
-$9.38M
5
KCM
Kingdon Capital Management
New York
-$8.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIT
26
BlackRock Institutional Trust
California
$9.66M -$1.44M -71,003 -15%
RA
27
Royce & Associates
New York
$8.33M +$6.92M +340,500 New
Citadel Advisors
28
Citadel Advisors
Florida
$8.05M +$6.68M +328,977 New
CCM
29
Century Capital Management
Massachusetts
$7.55M +$6.27M +308,482 New
Marshall Wace
30
Marshall Wace
United Kingdom
$7.08M +$4.34M +213,706 +283%
Deutsche Bank
31
Deutsche Bank
Germany
$6.38M +$1.73M +84,970 +48%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$5.54M +$1.18M +57,961 +34%
U
33
UBS
Switzerland
$3.98M -$8.17K -402 -0.2%
Charles Schwab
34
Charles Schwab
California
$3.98M +$833K +40,981 +34%
CS
35
Credit Suisse
Switzerland
$3.71M +$1.03M +50,584 +50%
CCM
36
Cadian Capital Management
New York
$3.67M +$3.05M +150,000 New
GP
37
GLG Partners
United Kingdom
$3.6M -$3.24M -159,527 -52%
TCIM
38
TIAA CREF Investment Management
New York
$3.36M -$91.6K -4,507 -3%
MSA
39
Mason Street Advisors
Wisconsin
$3.29M – – –
MAA
40
Managed Account Advisors
New Jersey
$3.25M -$93.4K -4,597 -3%
HH
41
HWG Holdings
Texas
$2.93M +$2.44M +119,869 New
Renaissance Technologies
42
Renaissance Technologies
New York
$2.68M -$2M -98,220 -47%
BIM
43
BlackRock Investment Management
Delaware
$2.55M +$17.7K +872 +0.8%
B
44
Baird
Wisconsin
$2.33M +$34.2K +1,684 +2%
PI
45
Putnam Investments
Massachusetts
$1.98M -$219K -10,800 -12%
LOAMS
46
Lombard Odier Asset Management (Switzerland)
Switzerland
$1.96M +$1.63M +80,000 New
ACM
47
Atika Capital Management
New York
$1.76M – – –
Goldman Sachs
48
Goldman Sachs
New York
$1.73M +$392K +19,287 +38%
USAA
49
United Services Automobile Association
Texas
$1.65M – – –
Allianz Asset Management
50
Allianz Asset Management
Germany
$1.64M -$67.8K -3,339 -5%
1
2
3 4 5

ANAC Hedge Fund Activity: Q3 2014 in Review

116 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2014, worth a combined $940M — up 58% from $596M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ANAC positions and 17 closed out — a net gain of 9 holders — while 39 added to existing stakes and 33 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $31.6M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $29.4M sold.

  • 116 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2014, up from 107 in Q2 2014.
  • Funds reported $940M of ANACOR PHARMACEUTICALS INC COM stock for Q3 2014, up 58% quarter-over-quarter.
  • 26 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2014 and 17 closed out, a net change of +9 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q3 2014 was Point72 Asset Management, an estimated $31.6M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2014 was Westfield Capital Management, an estimated $29.4M sold.

Based on aggregated 13F filings for Q3 2014.